CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models

Cited by (510)

Items 101–200 of 510

1. Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
   Zhu, Bing, Liu, Yan, Hwang, Spring, Archuleta, Kailey, Huang, Huijie, Campos, Alex, Murad, Rabi, Piña-Crespo, Juan, Xu, Huaxi, Huang, Timothy Y. · 2022 · Molecular Neurodegeneration
2. Synaptic Loss in Alzheimer's Disease: Mechanistic Insights Provided by Two-Photon in vivo Imaging of Transgenic Mouse Models
   Jaichandar Subramanian, Julie C. Savage, Marie‐Ève Tremblay · 2020 · Frontiers in Cellular Neuroscience
3. Targeting innate immunity for neurodegenerative disorders of the central nervous system
   Andreasson, Katrin I., Bachstetter, Adam D., Colonna, Marco, Ginhoux, Florent, Holmes, Clive, Lamb, Bruce, Landreth, Gary, Lee, Daniel C., Low, Donovan, Lynch, Marina A. et al. · 2016 · Journal of Neurochemistry
4. Neurovascular Coupling in Development and Disease: Focus on Astrocytes
   Teresa L. Stackhouse, Anusha Mishra · 2021 · Frontiers in Cell and Developmental Biology
5. Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway
   Lee, Sungho, Xu, Guixiang, Jay, Taylor R., Bhatta, Sabina, Kim, Ki-Wook, Jung, Steffen, Landreth, Gary E., Ransohoff, Richard M., Lamb, Bruce T. · 2014 · The Journal of Neuroscience
6. Pseudoginsenoside-F11 (PF11) exerts anti-neuroinflammatory effects on LPS-activated microglial cells by inhibiting TLR4-mediated TAK1/IKK/NF-κB, MAPKs and Akt signaling pathways
   Xiaoxiao Wang, Chunming Wang, Jiming Wang, Siqi Zhao, Kuo Zhang, Jingmin Wang, Wei Zhang, Chunfu Wu, Jingyu Yang · 2014 · Neuropharmacology
7. Microglia in Alzheimer’s Disease in the Context of Tau Pathology
   Juan Ramón Perea, Marta Bolós, Jesús Ávila · 2020 · Biomolecules
8. A microglia-cytokine axis to modulate synaptic connectivity and function
   Sebastian Werneburg, Philip A. Feinberg, Kasey M. Johnson, Dorothy P. Schafer · 2017 · Current Opinion in Neurobiology
9. Modulation of inflammation in transgenic models of Alzheimer’s disease
   Amy M. Birch, Loukia Katsouri, Magdalena Sastre · 2014 · Journal of Neuroinflammation
10. Activation of BV2 microglia by lipopolysaccharide triggers an inflammatory reaction in PC12 cell apoptosis through a toll-like receptor 4-dependent pathway
    Xiaojing Dai, Na Li, Le Yu, Zi-yang Chen, Rong Hua, Xia Qin, Yong-Mei Zhang · 2014 · Cell Stress and Chaperones
11. CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease
    Puntambekar, Shweta S., Moutinho, Miguel, Lin, Peter Bor-Chian, Jadhav, Vaishnavi, Tumbleson-Brink, Danika, Balaji, Ananya, Benito, Martin Alvarado, Xu, Guixiang, Oblak, Adrian, Lasagna-Reeves, Cristian A. et al. · 2022 · Molecular Neurodegeneration
12. Aging enhances classical activation but mitigates alternative activation in the central nervous system
    Daniel C. Lee, Claudia R. Ruiz, Lori A. Lebson, Maj‐Linda B. Selenica, Justin Rizer, Jerry B. Hunt, Rahil Rojiani, Patrick Reid, Sidharth Kammath, Kevin R. Nash et al. · 2013 · Neurobiology of Aging
13. Gut microbiota–driven brain Aβ amyloidosis in mice requires microglia
    Dodiya, Hemraj B., Lutz, Holly L., Weigle, Ian Q., Patel, Priyam, Michalkiewicz, Julia, Roman-Santiago, Carlos J., Zhang, Can Martin, Liang, Yingxia, Srinath, Abhinav, Zhang, Xulun et al. · 2022 · Journal of Experimental Medicine
14. Genetic targeting of microglia
    Peter Wieghofer, Klaus‐Peter Knobeloch, Marco Prinz · 2014 · Glia
15. Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies
    Guedes, Joana R., Lao, Taotao, Cardoso, Ana L., El Khoury, Joseph · 2018 · Frontiers in Neurology
16. Synaptic Elimination in Neurological Disorders
    Pablo Leal Cardozo, Izabella B. Q. de Lima, Esther M. A. Maciel, Nathália C. Silva, Tomáš Dobránsky, Fabiola Mara Ribeiro · 2019 · Current Neuropharmacology
17. Fractalkine in the nervous system: neuroprotective or neurotoxic molecule?
    Clotilde Lauro, Myriam Catalano, Flavia Trettel, Cristina Limatola · 2015 · Annals of the New York Academy of Sciences
18. Assessing the contribution of inflammation in models of Alzheimer's disease
    Hannah R. Johnston, Hervé Boutin, Stuart McRae Allan · 2011 · Biochemical Society Transactions
19. Magnolol improves Alzheimer's disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK/mTOR/ULK1 pathway
    Xuechu Wang, Jianping Jia · 2023 · Biomedicine & Pharmacotherapy
20. Suppression of Alzheimer-Associated Inflammation by Microglial Prostaglandin-E2EP4 Receptor Signaling
    Nathaniel S. Woodling, Qian Wang, Prachi G. Priyam, Paul B. Larkin, Ju Shi, Jenny U. Johansson, Irene A. Zagol-Ikapitte, Olivier G. Boutaud, Katrin I. Andreasson · 2014 · Journal of Neuroscience
21. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid  -Protein Oligomers
    Xu, H., Gelyana, E., Rajsombath, M., Yang, T., Li, S., Selkoe, D. · 2016 · Journal of Neuroscience
22. Central nervous system myeloid cells as drug targets: current status and translational challenges
    Knut P. H. Biber, Thomas Möller, Erik Boddeke, Marco Prinz · 2015 · Nature Reviews Drug Discovery
23. Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy
    Nash, Kevin R., Lee, Daniel C., Hunt, Jerry B., Morganti, Josh M., Selenica, Maj-Linda, Moran, Peter, Reid, Patrick, Brownlow, Milene, Guang-Yu Yang, Clement, Savalia, Miloni et al. · 2013 · Neurobiology of Aging
24. Microglia and inflammation: conspiracy, controversy or control?
    Adelaide Maria Afonso Fernandes, Leonor Miller‐Fleming, Teresa Faria Pais · 2014 · Cellular and Molecular Life Sciences
25. Time-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injury
    Febinger, Heidi Y., Thomasy, Hannah E., Pavlova, Maria N., Ringgold, Kristyn M., Barf, Paulien R., George, Amrita M., Grillo, Jenna N., Bachstetter, Adam D., Garcia, Jenny A., Cardona, Astrid E. et al. · 2015 · Journal of Neuroinflammation
26. Plasticity of microglia
    Marcus Augusto‐Oliveira, Gabriela de Paula Arrifano, Charlotte Isabelle Delage, Marie‐Ève Tremblay, Maria Elena Crespo Lopez, Alexei Verkhratsky · 2021 · Biological reviews/Biological reviews of the Cambridge Philosophical Society
27. Fractalkine Over Expression Suppresses α-Synuclein-mediated Neurodegeneration
    Kevin R. Nash, Peter Moran, Dylan J. Finneran, Charles Hudson, Jesse Robinson, David Morgan, Paula C. Bickford · 2014 · Molecular Therapy
28. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice
    Babcock, Alicia A., Ilkjær, Laura, Clausen, Bettina H., Villadsen, Birgitte, Dissing-Olesen, Lasse, Bendixen, Anita T.M., Lyck, Lise, Lambertsen, Kate L., Finsen, Bente · 2015 · Brain, Behavior, and Immunity
29. G Protein-Coupled Receptors (GPCRs) in Alzheimer’s Disease: A Focus on BACE1 Related GPCRs
    Juan Zhao, Yulin Deng, Zhaotan Jiang, Hong Qing · 2016 · Frontiers in Aging Neuroscience
30. Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss
    Michael X. Hernandez, Shan Jiang, Tracy A. Cole, Shu‐Hui Chu, Maria I. Fonseca, Melody J. Fang, Lindsay A. Hohsfield, Maria D. Torres, Kim N. Green, Rick A. Wetsel et al. · 2017 · Molecular Neurodegeneration
31. <i>Cx3cr1-</i> deficient microglia exhibit a premature aging transcriptome
    Gyoneva, Stefka, Hosur, Raghavendra, Gosselin, David, Zhang, Baohong, Ouyang, Zhengyu, Cotleur, Anne C, Peterson, Michael, Allaire, Norm, Challa, Ravi, Cullen, Patrick et al. · 2019 · Life Science Alliance
32. Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents
    Łukasz A. Poniatowski, Piotr Wojdasiewicz, Maciej Krawczyk, Dariusz Szukiewicz, Robert Gasik, Łukasz Kubaszewski, Iwona Kurkowska‐Jastrzębska · 2016 · Molecular Neurobiology
33. BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia
    Ari Sudwarts, Supriya Ramesha, Tianwen Gao, Moorthi Ponnusamy, Shuai Wang, Mitchell T. Hansen, Alena Kozlova, Sara Bitarafan, Prateek Kumar, David Beaulieu‐Abdelahad et al. · 2022 · Molecular Neurodegeneration
34. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy
    Aurélie Joly‐Amado, Jordan Hunter, Zainuddin Quadri, Frank Zamudio, Patricia Rocha-Rangel, Deanna Chan, Anisha Kesarwani, Kevin R. Nash, Daniel C. Lee, David Morgan et al. · 2020 · Frontiers in Immunology
35. Innate Immunity Fights Alzheimer's Disease
    Marie‐Victoire Guillot‐Sestier, Kevin R. Doty, Terrence Town · 2015 · Trends in Neurosciences
36. Alzheimer's disease pathophysiology in the Retina
    Bhakta Prasad Gaire, Yosef Koronyo, Dieu-Trang S. Fuchs, Haoshen Shi, Altan Rentsendorj, Ron Danziger, Jean‐Philippe Vit, Nazanin Mirzaei, Jonah Doustar, Julia Sheyn et al. · 2024 · Progress in Retinal and Eye Research
37. MicroRNA-195 prevents hippocampal microglial/macrophage polarization towards the M1 phenotype induced by chronic brain hypoperfusion through regulating CX3CL1/CX3CR1 signaling
    Meng Mao, Yi Xu, Xinyu Zhang, Lin Cheng Yang, Xiaobin An, Yang Qu, Ya-ni Chai, Yan-Ru Wang, Tingting Li, Jing Ai · 2020 · Journal of Neuroinflammation
38. Age-related changes in tissue macrophages precede cardiac functional impairment
    Alexander Ruvantha Pinto, James W. Godwin, Anjana Ravi Chandran, Lucy Hersey, Alexei Ilinykh, Ryan J. Debuque, Lina Wang, Nadia A Rosenthal · 2014 · Aging
39. Role of Atypical Chemokine Receptors in Microglial Activation and Polarization
    Valentina Salvi, Francesca Sozio, Silvano Sozzani, Annalisa Del Prete · 2017 · Frontiers in Aging Neuroscience
40. The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects
    Ophélia Le Thuc, Nicolas Blondeau, Jean‐Louis Nahon, Carole Rovère · 2015 · Annals of the New York Academy of Sciences
41. APOE Isoforms Control Pathogenic Subretinal Inflammation in Age-Related Macular Degeneration
    Olivier Levy, Sophie Lavalette, Shulong Justin Hu, Michael Housset, William Raoul, Chiara Maria Eandi, José‐Alain Sahel, Patrick M. Sullivan, Xavier Guillonneau, Florian Sennlaub · 2015 · Journal of Neuroscience
42. Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation
    Hariharakrishnan Chidambaram, Rashmi Ranjan Das, Subashchandrabose Chinnathambi · 2020 · Cell & Bioscience
43. Role of Chemokines in the Development and Progression of Alzheimer’s Disease
    Wojcieszak, Jakub, Kuczyńska, Katarzyna, Zawilska, Jolanta B. · 2022 · Journal of Molecular Neuroscience
44. Microglia in Alzheimer's Disease: It's All About Context
    Weitz, Tara M., Town, Terrence · 2012 · International Journal of Alzheimer's Disease
45. Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain
    Maj‐Linda B. Selenica, Jennifer A. Alvarez, Kevin R. Nash, Daniel C. Lee, Chuanhai Cao, Xiaoyang Lin, Patrick Reid, Peter R. Mouton, David Morgan, Marcia N. Gordon · 2013 · Journal of Neuroinflammation
46. A Brief History of Microglial Ultrastructure: Distinctive Features, Phenotypes, and Functions Discovered Over the Past 60 Years by Electron Microscopy
    Julie C. Savage, Katherine Picard, Fernando Gonzàlez Ibáñez, Marie‐Ève Tremblay · 2018 · Frontiers in Immunology
47. A novel in vitro human microglia model: Characterization of human monocyte-derived microglia
    Samar Etemad, Rasheeda Mohd Zamin, Marc Jan Ruitenberg, Luis Filgueira · 2012 · Journal of Neuroscience Methods
48. Fractalkine/<scp>CX</scp>3<scp>CL</scp>1 modulates <scp>GABA</scp>_A currents in human temporal lobe epilepsy
    Roseti, Cristina, Fucile, Sergio, Lauro, Clotilde, Martinello, Katiuscia, Bertollini, Cristina, Esposito, Vincenzo, Mascia, Addolorata, Catalano, Myriam, Aronica, Eleonora, Limatola, Cristina et al. · 2013 · Epilepsia
49. Loss of tau rescues inflammation-mediated neurodegeneration
    Maphis, Nicole, Xu, Guixiang, Kokiko-Cochran, Olga N., Cardona, Astrid E., Ransohoff, Richard M., Lamb, Bruce T., Bhaskar, Kiran · 2015 · Frontiers in Neuroscience
50. Macrophages in cardiac homeostasis, injury responses and progenitor cell mobilisation
    Alexander Ruvantha Pinto, James W. Godwin, Nadia A Rosenthal · 2014 · Stem Cell Research
51. Role of fractalkine–CX3CR1 pathway in seizure-induced microglial activation, neurodegeneration, and neuroblast production in the adult rat brain
    Idrish Yunus Ali, Deepti Chugh, Christine T. Ekdahl · 2014 · Neurobiology of Disease
52. Cortical microhemorrhages cause local inflammation but do not trigger widespread dendrite degeneration
    Rosidi, Nathanael L., Zhou, Joan, Pattanaik, Sanket, Wang, Peng, Jin, Weiyang, Brophy, Morgan, Olbricht, William L., Nishimura, Nozomi, Schaffer, Chris B. · 2011 · PLoS ONE
53. Fractalkine/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases.
    Piao Luo, Shi-Feng Chu, Zhao Zhang, Cong-yuan Xia, Nai-Hong Chen · 2019 · Brain Research Bulletin
54. Role of CX3CL1 in Diseases
    Wangmi Liu, Libo Jiang, Chong Bian, Yun Liang, Rong Xing, Mumingjiang Yishakea, Jian Dong · 2016 · Archivum Immunologiae et Therapiae Experimentalis
55. Selective Brain-Targeted Antagonism of p38 MAPKα Reduces Hippocampal IL-1β Levels and Improves Morris Water Maze Performance in Aged Rats
    John J. Alam · 2015 · Journal of Alzheimer s Disease
56. The Potential Role of Chemokines in Alzheimer’s Disease Pathogenesis
    Gholamreza Azizi, Nikoo Hossein‐Khannazer, Abbas Mirshafiey · 2014 · American Journal of Alzheimer s Disease & Other Dementias®
57. Chemokine receptor CXCR2: Physiology regulator and neuroinflammation controller?
    Mike Veenstra, Richard M. Ransohoff · 2012 · Journal of Neuroimmunology
58. Cognitive and Behavioral Consequences of Impaired Immunoregulation in Aging
    Angela W. Corona, Ashley M. Fenn, Jonathan P. Godbout · 2011 · Journal of Neuroimmune Pharmacology
59. Recent Progress in Alzheimer’s Disease Research, Part 1: Pathology
    Francis T. Hane, Brenda Yasie Lee, Zoya Leonenko · 2017 · Journal of Alzheimer s Disease
60. The Evolving Dialogue of Microglia and Neurons in Alzheimer’s Disease: Microglia as Necessary Transducers of Pathology
    Simon, E., Obst, J., Gomez-Nicola, D. · 2019 · Neuroscience
61. The Oxygen Paradox, the French Paradox, and age-related diseases
    Davies, Joanna M. S., Cillard, Josiane, Friguet, Bertrand, Cadenas, Enrique, Cadet, Jean, Cayce, Rachael, Fishmann, Andrew, Liao, David, Bulteau, Anne-Laure, Derbré, Frédéric et al. · 2017 · GeroScience
62. Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies
    Elisa Ferretti, Vito Pistoia, Anna Corcione · 2014 · Mediators of Inflammation
63. The Evolving Biology of Microglia in Alzheimer's Disease
    Malm, Tarja M., Jay, Taylor R., Landreth, Gary E. · 2015 · Neurotherapeutics
64. Glial Modulators as Potential Treatments of Psychostimulant Abuse
    Patrick M. Beardsley, Kurt F. Hauser · 2014 · Advances in pharmacology
65. Tau hyperphosphorylation and P-CREB reduction are involved in acrylamide-induced spatial memory impairment: Suppression by curcumin
    Dandan Yan, Jianling Yao, Ying Liu, Xing Zhang, Yiqi Wang, Xiaoyi Chen, Liegang Liu, Nian Shi, Hong Yan · 2018 · Brain Behavior and Immunity
66. IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology
    Isabelle St‐Amour, Isabelle Paré, Cyntia Tremblay, Katherine Coulombe, Renée Bazin, Frédéric Calon · 2014 · Journal of Neuroinflammation
67. Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice
    Hickman, Suzanne E., Allison, Elizabeth K., Coleman, Uwanda, Kingery-Gallagher, Nathan D., El Khoury, Joseph · 2019 · Frontiers in Immunology
68. Microglia as a critical player in both developmental and late-life CNS pathologies
    Derecki, Noël C., Katzmarski, Natalie, Kipnis, Jonathan, Meyer-Luehmann, Melanie · 2014 · Acta Neuropathologica
69. The microglial fractalkine receptor is not required for activity-dependent plasticity in the mouse visual system
    Rebecca L. Lowery, Marie‐Ève Tremblay, Brittany E. Hopkins, Ania Katarzyna Majewska · 2017 · Glia
70. Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
    Natalia Salvadores, Inés Moreno‐González, Nazaret Gamez, Gabriel Quiroz, Laura Vegas‐Gomez, Marcela Escandón, Sebastián Jiménez, Javier Vitórica, Antonia Gutiérrez, Claudio A. Soto et al. · 2022 · Acta Neuropathologica Communications
71. Physical Exercise-Induced Myokines in Neurodegenerative Diseases
    Lee, Banseok, Shin, Myeongcheol, Park, Youngjae, Won, So-Yoon, Cho, Kyoung Sang · 2021 · International Journal of Molecular Sciences
72. Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer’s disease through inhibition of inflammation
    Malm, Tarja, Mariani, Monica, Donovan, Lauren J, Neilson, Lee, Landreth, Gary E · 2015 · Journal of Neuroinflammation
73. Alzheimer’s disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation
    Shehata Anwar, Serge Rivest · 2020 · Expert Opinion on Therapeutic Targets
74. Amyloid ß and Tau Alzheimer¿s disease related pathology is reduced by toll-like receptor 9 stimulation
    Henrieta Scholtzova, Peter E. Chianchiano, Jason Pan, Yanjie Sun, Fernando Goñi, Pankaj D Mehta, Thomas Wısnıewskı · 2014 · Acta Neuropathologica Communications
75. Hematopoietic CC-Chemokine Receptor 2 (CCR2) Competent Cells Are Protective for the Cognitive Impairments and Amyloid Pathology in a Transgenic Mouse Model of Alzheimer’s Disease
    Gaëlle Naert, Serge Rivest · 2011 · Molecular Medicine
76. Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
    Md. Sahab Uddin, Md. Tanvir Kabir, Maroua Jalouli, Md. Ataur Rahman, Philippe Jeandet, Tapan Behl, Athanasios T. Alexiou, Ghadeer Mohsen Albadrani, Mohamed M. Abdel‐Daim, Asma Perveen et al. · 2021 · Current Neuropharmacology
77. Rod microglia and their role in neurological diseases
    Olivia G. Holloway, Alison Jane Canty, Anna Elizabeth King, Jenna M. Ziebell · 2019 · Seminars in Cell and Developmental Biology
78. The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets
    AmeliMojarad, Melika, AmeliMojarad, Mandana · 2024 · CNS Neuroscience &amp; Therapeutics
79. Innate Immunity in Alzheimer’s Disease: A Complex Affair
    Marie‐Victoire Guillot‐Sestier, Terrence Town · 2013 · CNS & Neurological Disorders - Drug Targets
80. Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies
    Violetta Refolo, Nadia Stefanova · 2019 · Frontiers in Cellular Neuroscience
81. Alterations to the Frequency and Function of Peripheral Blood Monocytes and Associations with Chronic Disease in the Advanced-Age, Frail Elderly
    Chris P. Verschoor, Jennie Johnstone, Jamie Millar, Robin Parsons, Alina Lelic, Mark B Loeb, Jonathan L. Bramson, Dawn M. E. Bowdish · 2014 · PLoS ONE
82. Responses of rat and mouse primary microglia to pro- and anti-inflammatory stimuli: molecular profiles, K+ channels and migration
    Doris Lam, Starlee S. Lively, Lyanne C. Schlichter · 2017 · Journal of Neuroinflammation
83. The Receptor for Advanced Glycation Endproducts (RAGE) and Mediation of Inflammatory Neurodegeneration
    Derk, Julia, MacLean, Michael, Juranek, Judyta, Schmidt, Ann Marie · 2018 · Journal of Alzheimer’s Disease &amp; Parkinsonism
84. Adult microglial TGFβ1 is required for microglia homeostasis via an autocrine mechanism to maintain cognitive function in mice
    Alicia Bedolla, Elliot Wegman, Max Weed, Messiyah K. Stevens, Kierra Ware, Aditi Paranjpe, Anastasia Alkhimovitch, Igal Ifergan, Александр Таранов, Joshua D. Peter et al. · 2024 · Nature Communications
85. The Emerging Role of the Interplay Among Astrocytes, Microglia, and Neurons in the Hippocampus in Health and Disease
    Daniele Lana, Filippo Ugolini, Daniele Nosi, Gary L. Wenk, Maria Grazia Giovannini · 2021 · Frontiers in Aging Neuroscience
86. Targeting Microglia in Alzheimer’s Disease: Pathogenesis and Potential Therapeutic Strategies
    Sun, Zhongqing, Zhang, Xin, So, Kwok-Fai, Jiang, Wen, Chiu, Kin · 2024 · Biomolecules
87. Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy
    M. Hebron, I. Lonskaya, Paul Olopade, S. Selby, F. Pagán, C. Moussa · 2014 · Journal of Clinical & Cellular Immunology
88. Cellular and Molecular Mediators of Neuroinflammation in Alzheimer Disease
    Seung‐Hoon Yang · 2019 · International Neurourology Journal
89. CX3CR1‐dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation
    Laura Hertwig, Isabell Hamann, Silvina Romero‐Suárez, Jason Michael Millward, R Pietrek, Coralie Chanvillard, Hanna Stuis, Karolin Pollok, Richard M. Ransohoff, Astrid E. Cardona et al. · 2016 · European Journal of Immunology
90. Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease
    Aaron D. Thome, David G. Standaert, Ashley S. Harms · 2015 · PLoS ONE
91. Rapid morphologic changes to microglial cells and upregulation of mixed microglial activation state markers induced by P2X7 receptor stimulation and increased intraocular pressure
    Keith E. Campagno, Wennan Lu, Assraa Hassan Jassim, Farraj Albalawi, Aurora Cenaj, Huen‐Yee Tso, Sophia P. Clark, Puttipong Sripinun, Néstor Más Gómez, Claire H. Mitchell · 2021 · Journal of Neuroinflammation
92. The Biphasic Role of Microglia in Alzheimer's Disease
    Tetsuya Mizuno · 2012 · International Journal of Alzheimer s Disease
93. Therapeutic Potential of Mesenchymal Stromal Cells and MSC Conditioned Medium in Amyotrophic Lateral Sclerosis (ALS) - In Vitro Evidence from Primary Motor Neuron Cultures, NSC-34 Cells, Astrocytes and Microglia
    Hui Juan Sun, Karelle Bénardais, Nancy Stanslowsky, Nadine Thau‐Habermann, Niko Hensel, Dongya Huang, Peter Claus, Reinhard Dengler, Martin Stangel, Susanne Petri · 2013 · PLoS ONE
94. Microglia Mediate HIV-1 gp120-Induced Synaptic Degeneration in Spinal Pain Neural Circuits
    Wenjuan Ru, Xin Liu, Chilman Bae, Yuqiang Shi, Randall S. Walikonis, Jin Mo Chung, Shao‐Jun Tang · 2019 · Journal of Neuroscience
95. CX 3 CR1 deficiency delays acute skeletal muscle injury repair by impairing macrophage functions
    Wanming Zhao, Haiyan Lu, Xingyu Wang, Richard M. Ransohoff, Lan Zhou · 2015 · The FASEB Journal
96. CX3CL1/CX3CR1 in Alzheimer’s Disease: A Target for Neuroprotection
    Peiqing Chen, Wenjuan Zhao, Yanjie Guo, Juan Xu, Ming Yin · 2016 · BioMed Research International
97. Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson’s disease: Potential clinical and therapeutic implications
    Efthalia Angelopoulou, Yam Nath Paudel, Mohd. Farooq Shaikh, Christina Piperi · 2020 · Pharmacological Research
98. Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice
    Aimee N. Winter, Meena S. Subbarayan, Bethany A. Grimmig, Jason A. Weesner, Lauren D. Moss, Melinda M. Peters, Edwin J. Weeber, Kevin R. Nash, Paula C. Bickford · 2020 · Journal of Neuroinflammation
99. Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain.
    Carmelina Gemma, Adam D. Bachstetter, Paula C. Bickford · 2010 · Europe PMC (PubMed Central)
100. Real-time analysis of microglial activation and motility in hepatic and hyperammonemic encephalopathy
     Vinita Rangroo Thrane, Alexander Stanley Thrane, J. CHANAG, V. Alleluia, Erlend Arnulf Nagelhus, Maiken Nedergaard · 2012 · Neuroscience